Third Wave, Shimadzu, Toppan to Develop Point-of-Care Device for Avoiding ADRs

Mar 02, 2006

NEW YORK, March 2 (GenomeWeb News) - Third Wave Technologies, Shimadzu, and Toppan Printing plan to co-develop and commercialize a point-of-care device that aims to prevent adverse drug reactions, the companies said today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Osamu Shimomura Dies

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

Retirement Moves

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

This Week in PLOS

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Shuffle at IBM Watson Health

Stat News reports that the head of IBM Watson Health is leaving her post.

Main menu